The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sanofi via Globenewswire
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89.86 EUR | +0.38% | +0.79% | +0.11% |
27/05 | Sanofi Gets US FDA’s Priority Review for Expanded Use of Blood Cancer Drug Sarclisa | MT |
27/05 | Sanofi: FDA grants priority review in myeloma | CF |
1st Jan change | Capi. | |
---|---|---|
+0.11% | 122B | |
+38.51% | 727B | |
+31.74% | 594B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.44% | 205B | |
-5.97% | 203B | |
+6.19% | 164B |